• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number 0008021026
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Non specific EKG/ECG Changes (1817); Vasoconstriction (2126)
Event Date 09/05/2023
Event Type  Injury  
Event Description
Clinical study name: faradise.Clinical study id: (b)(6).Patient id: (b)(6).It was reported after a procedure using a farawave pulsed field ablation catheter the patient experienced st segment elevation from a coronary spasm.The patient was hospitalized and a coronary angiogram was conducted.No lesions were observed.The st segment elevation reversed spontaneously two days later and the patient was discharged.The device is not expected to be returned for analysis.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
Clinical study name: (b)(6) clinical study id: (b)(6) patient id: (b)(6).It was reported after a procedure using a farawave pulsed field ablation catheter the patient experienced st segment elevation from a coronary spasm.The patient was hospitalized and a coronary angiogram was conducted.No lesions were observed.The st segment elevation reversed spontaneously two days later and the patient was discharged.The device is not expected to be returned for analysis.Coronary spasm was not confirmed by the angiography and was only suspected.
 
Manufacturer Narrative
Correction to the previously reported bsc aware date from (b)(6) 2023 to (b)(6)2024 as the event became reportable based on additional information that the patient was hospitalized received on (b)(6) 2024.Correction to previously reported h6 patient codes.The code e0516 vasoconstriction was removed as that complication was only speculated and not clinically confirmed.It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
Clinical study name: faradise, clinical study id: (b)(6).It was reported after a procedure using a farawave pulsed field ablation catheter the patient experienced st segment elevation from a coronary spasm.The patient was hospitalized and a coronary angiogram was conducted.No lesions were observed.The st segment elevation reversed spontaneously two days later and the patient was discharged.The device is not expected to be returned for analysis.
 
Manufacturer Narrative
Correction to the previously reported bsc aware date from 28-dec-2023 to 19-feb-2024 as the event became reportable based on additional information that the patient was hospitalized received on 19-feb-2024.It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer (Section G)
AGILE MV INC
3700 st patrick st suite 102
montreal, qc H4E 1 A2
CA   H4E 1A2
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18810618
MDR Text Key336588361
Report Number2124215-2024-12283
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number0008021026
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/28/2023
Initial Date FDA Received02/29/2024
Supplement Dates Manufacturer Received02/19/2024
03/29/2024
Supplement Dates FDA Received03/01/2024
04/18/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age67 YR
Patient SexFemale
Patient Weight65 KG
-
-